Project Grant R44EY039153
- Federal Grant Award Summary Carolina Instruments, Inc. received a $313,927 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), awarded July 15, 2026, with completion targeted for May 31, 2027. The company is developing PUPIL-LIGHT, a wearable platform technology designed to capture high-speed, high-fidelity measurements of saccades (rapid eye movements), microsaccades, and pupil dynamics in real-time. The device addresses critical limitations in...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded The Aird a $610,000 Project Grant under the Vision Research program (CFDA 93.867) effective September 1, 2025, through August 31, 2026. This award funds the development and commercialization of an adaptive optics optical coherence tomography (AO-OCT) system designed for high-resolution, wide-field retinal imaging in small animal models, specifically mice. The primary deliverables include a portable AO-OCT imaging system...
- Federal Grant Award Summary Eye C Better Corp received a $315,825 Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective September 1, 2025, with a completion date of May 31, 2027. The project develops Photonic Intraocular Pressure (IOP) Biomonitoring (PIB), a non-invasive, non-contact tonometry method for measuring intraocular pressure in glaucoma patients. The technology uses sound wave-induced scleral oscillations detected through...
- Federal Project Grant Award Summary Kineolabs, Inc. received a $300,001 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to develop a portable, low-cost line-scan swept-source optical coherence tomography imaging system (LS-SS-OCT). The system is designed for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases. The one-year project, which commenced July 1, 2025 and concludes June...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded a $421,136 Project Grant to the University of Maryland, College Park, effective August 1, 2025, through July 31, 2027, under the Vision Research program (CFDA 93.867). This award supports research into advanced wavefront shaping techniques designed to enable high-resolution fundus imaging in patients with ocular opacities—conditions affecting the cornea and lens that currently prevent effective posterior segment eye...
- Federal Project Grant Award Summary Oregon Health & Science University received a $1.73 million Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective September 1, 2025, through April 30, 2030. The grant funds development of innovative ophthalmic imaging technologies and objective biomarkers to assess photoreceptor function and integrity in patients with retinal degeneration. The project delivers two primary products: (1)...
- Federal Grant Award Summary Universal Adherence LLC received a $912,573 Project Grant from the National Eye Institute under the Vision Research program (CFDA 93.867) for the period of July 1, 2025 through June 30, 2027. The award supports the development and clinical testing of the iDrop Device (ID2), a smart electronic cap monitor designed to improve medication adherence for patients using prescribed eye drops. The device automatically tracks when patients remove eye drop bottle caps,...
- Federal Project Grant Award Summary The National Eye Institute (NEI) awarded Boston Children's Hospital a $534,000 Project Grant under the Vision Research program (CFDA 93.867) for a two-year planning initiative (April 1, 2026 – March 31, 2028) to develop a clinical and regulatory pathway for treating pediatric inherited retinal disorders (IRDs) using antisense oligonucleotide (ASO) therapeutics. The deliverables include: (1) streamlined genetic eligibility analysis to identify cryptic...
- Federal Grant Award Summary Boston Children's Hospital received a $136,512 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) effective July 1, 2025, through June 30, 2027. The award supports research investigating how intrinsically photosensitive retinal ganglion cells (ipRGCs) transform light information in melanopsin pathways to regulate physiological and behavioral responses. The research employs advanced imaging techniques to measure...
- Federal Grant Award Summary Electric Indigo, LLC received a $356,807 Phase I Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), awarded on September 30, 2025, with completion targeted for August 31, 2026. The project delivers two primary products: (1) development of an advanced prototype indigo light-emitting eyewear device engineered for low-volume production with formal safety evaluation, and (2) a pilot clinical feasibility study conducted...
Funding Agency and Program: The National Eye Institute awarded this $906,443 Project Grant under the Vision Research program (CFDA 93.867) on July 1, 2026, to support commercialization of a pediatric retinal imaging device. Products and Services Delivered: Biolight Engineering LLC, in collaboration with the University of Illinois Chicago, the University of Chicago, and Children's Hospital Los Angeles, is developing PedCam, an ultra-widefield, nonmydriatic pediatric fundus camera designed to address critical gaps in retinal imaging for premature infants at risk for retinopathy of prematurity (ROP) and other pediatric retinal diseases. The project deliverables include: (1) fabrication of five minimal viable product PedCam systems featuring integrated pupil-matching control, adjustable illumination, autofocusing, and high dynamic range imaging capabilities; (2) clinical validation across three partner institutions involving imaging data collection from over 180 patients (360+ image sets) to compare PedCam performance against RetCam and traditional indirect ophthalmoscopy; and (3) completion of safety testing and regulatory documentation required for FDA clearance. The innovation employs patented trans-pars-planar illumination technology to achieve ultra-widefield (200-degree) imaging without pharmacologic pupil dilation at substantially lower cost than existing alternatives, with anticipated completion by May 31, 2028.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $906.4k | 7/7/26 |